Article
As part of its commitment to the field of ophthalmology, Pfizer Inc. has developed and funded several philanthropic programs in the area of eye care.
Age and gender may play a part in patient outcomes following ocular gene therapy
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
TECLens, Inc. raises $9.3 million in Series A round for refractive technology
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Stanford study finds new approach to choroidal tumor measurement
Study highlights strong parental cooperation in preschool vision screening